Recorded: EpiVax EPV-CoV-19 Vaccine Webinar

by Annie De Groot | Sep 21, 2020 | Events, Webinars

Thank you for your continued interest in the status of our EpiVax’s EPV-CoV-19 Vaccine Program. This event has passed! But do not fear, there is a recording of the session available for access. Kindly fill out the information form linked below and an email...

Press Release: Intravacc and EpiVax team up in development of COVID-19 emerging vaccine

by Adam | Jun 2, 2020 | News

Bilthoven, The Netherlands, Providence, R.I., USA, 2 June 2020 –  Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, and EpiVax, a...

Press Release: PharmaJet partners with Immunomic Therapeutics and EpiVax to develop and deliver COVID-19 Vaccine

by Adam | Apr 15, 2020 | News

Originally published via PR Newswire  GOLDEN, Colo., April 14, 2020 /PRNewswire/ — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its Tropis® Needle-free injection system will be used to deliver a COVID-19 vaccine...

Press Release: Immunomic Therapeutics Forms Collaboration with EpiVax and PharmaJet to Develop Novel Vaccine Candidate Against COVID-19 Using its Investigational UNITE Platform

by Adam | Apr 9, 2020 | News

Read the original BusinessWire publication here. ROCKVILLE, MD, PROVIDENCE, RI, and GOLDEN, CO, April 09, 2020 — Immunomic Therapeutics, Inc., a privately held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms,...

Press Release: EpiVax Partners with GAIA Vaccine Foundation to Make COVID-19 Vaccine License Free to Developing Countries

by Adam | Apr 7, 2020 | News

PROVIDENCE, RI, April 7, 2020 /PRNewswire/ — EpiVax, Inc., is using advanced computational tools to accelerate a COVID-19 vaccine candidate (EPV-CoV19) for healthcare workers (HCW) into clinical trials in 6 months. Today, EpiVax announces its partnership with...